| COVID-19 |
1 |
0.74 |
| Immunoglobulin G (IgG) |
0 |
0.7 |
| Immunization |
0 |
0.68 |
| COVID-19 Vaccine |
0 |
0.62 |
| Severe Acute Respiratory Syndrome |
0 |
0.38 |
| Biologic Therapy |
0 |
0.35 |
| Acute Respiratory Distress Syndrome |
0 |
0.33 |
| Multiple Sclerosis |
0 |
0.33 |
| Vaccines |
0 |
0.27 |
| Monoclonal Antibody |
0 |
0.23 |
| Scan |
0 |
0.23 |
| Patient Safety |
0 |
0.22 |
| Antineoplastic Drug |
0 |
0.15 |
| Receptors |
0 |
0.15 |
| Disability |
0 |
0.08 |
| Disease-Modifying Therapy |
0 |
0.08 |
| Insurance |
0 |
0.08 |
| Lymphocytes |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.07 |